title: Is Alzheimer's Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?
abstract: The Alzheimer's Association recently reported that a woman's estimated lifetime risk of developing Alzheimer's at age 65 is 1 in 6, compared to nearly 1 in 11 for a man (ie, female to male ratio 1.8). Based on female to male ratio, Alzheimer's disease could well be an autoimmune disorder. Like Alzheimer's, multiple sclerosis, an autoimmune inflammation of the central nervous system, has a female to male ratio of 2.3. Also based on female to male ratio, Alzheimer's resembles the autoimmune inflammatory disease rheumatoid arthritis, which has a female to male ratio of 2.7. The reasons for the female preponderance in autoimmune disease are unclear, but nonsteroidal anti-inflammatory drugs (NSAIDs) are widely and successfully employed to treat autoimmune anti-inflammatory disease and dramatically relieve symptoms. Moreover, oral NSAIDs consistently reduce the risk of Alzheimer's disease, although they have been totally ineffective as a treatment in multiple failed clinical trials. A basis for this failure might well be that the brain dose after oral administration is too small and not sufficiently early in the pathogenesis of the disorder. But NSAID brain dose could be significantly increased by delivering the NSAIDs intranasally.
authors.affiliation: Fermata Pharma, Inc, New York, NY, USA steven@fermatapharma.com.
authors.forename: Steven
authors.initials: S
authors.lastname: Lehrer
authors.affiliation: Severn Health Solutions, Severna Park, MD, USA.
authors.forename: Peter H
authors.initials: PH
authors.lastname: Rheinstein
mesh_terms: D000281:Administration, Intranasal; D000368:Aged; D000544:Alzheimer Disease / Q000453:epidemiology / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D020274:Autoimmune Diseases of the Nervous System / Q000453:epidemiology / Q000517:prevention & control*; D001921:Brain / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal
keywords: NSAIDs; autoimmunity; brain; nasal
references.citation: Arch Neurol. 2012 Jan;69(1):29-38
references.pmid: 21911655
references.citation: J Autoimmun. 2009 Aug;33(1):12-6
references.pmid: 19356902
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7
references.pmid: 12826605
references.citation: Alzheimers Dement. 2015 Mar;11(3):310-320
references.pmid: 24418058
references.citation: N Engl J Med. 2002 Sep 19;347(12):911-20
references.pmid: 12239261
references.citation: Trends Pharmacol Sci. 2005 Oct;26(10):517-25
references.pmid: 16126283
references.citation: Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):401-3
references.pmid: 24413537
references.citation: Neurology. 1997 Mar;48(3):626-32
references.pmid: 9065537
references.citation: PLoS One. 2012;7(2):e31302
references.pmid: 22312444
references.citation: Neurobiol Aging. 2004 May-Jun;25(5):675-83
references.pmid: 15172747
references.citation: Neurology. 1998 Apr;50(4):966-71
references.pmid: 9566380
references.citation: Panminerva Med. 1996 Mar;38(1):61-3
references.pmid: 8766884
references.citation: Med J Aust. 1994 Feb 7;160(3):117-22
references.pmid: 8295576
references.citation: Pharm Res. 2006 May;23(5):873-81
references.pmid: 16715377
references.citation: J Pharmacol Exp Ther. 2007 Jun;321(3):823-9
references.pmid: 17229880
references.citation: Alzheimers Dement. 2014 Mar;10(2):e47-92
references.pmid: 24818261
references.citation: Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006378
references.pmid: 22336816
references.citation: J Neuropsychiatry Clin Neurosci. 2004 Winter;16(1):120-1
references.pmid: 14990773
references.citation: Lupus. 2006;15(11):753-6
references.pmid: 17153846
references.citation: Expert Opin Drug Deliv. 2012 Jan;9(1):19-31
references.pmid: 22171740
references.citation: Toxicol Appl Pharmacol. 1969 Sep;15(2):310-30
references.pmid: 5817060
references.citation: Brain Res. 2003 Aug 22;982(1):19-30
references.pmid: 12915236
references.citation: JAMA. 2014 Apr 23-30;311(16):1596-8
references.pmid: 24718971
references.citation: J Alzheimers Dis. 2014;40(2):465-73
references.pmid: 24448786
references.citation: Nat Immunol. 2007 Sep;8(9):913-9
references.pmid: 17712344
references.citation: Science. 2013 Jan 11;339(6116):166-72
references.pmid: 23307734
references.citation: Am J Epidemiol. 2002 Sep 1;156(5):445-53
references.pmid: 12196314
references.citation: Curr Alzheimer Res. 2006 Jul;3(3):229-35
references.pmid: 16842100
references.citation: Rheumatology (Oxford). 2002 Jul;41(7):793-800
references.pmid: 12096230
references.citation: Neurobiol Aging. 2009 Aug;30(8):1184-91
references.pmid: 18079025
references.citation: Arch Neurol. 2000 Jun;57(6):808-13
references.pmid: 10867777
references.citation: Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006346
references.pmid: 22315714
references.citation: Med Hypotheses. 2005;64(3):458-63
references.pmid: 15617848